Abnormal, suggestive of TB (n=385) | Abnormal, other (n=737) | Total (n=1123) | P value | |
Sex | <0.001 | |||
Missing | 0 | 1 | 1 | |
Female | 198 (51.4%) | 570 (70.8%) | 720 (64.2%) | |
Male | 187 (48.6%) | 239 (29.2%) | 402 (35.8%) | |
Age (years) | <0.001 | |||
Median (Q1, Q3) | 45.0 (33.0, 64.0) | 54.0 (38.0, 67.0) | 51.0 (36.2, 66.0) | |
Study consensus interpretation | <0.001 | |||
Abnormal CXR | 247 (64.2%) | 353 (49.0%) | 600 (53.4%) | |
Normal CXR | 138 (35.8%) | 384 (52.1%) | 522 (46.6%) | |
Missing | 1 | |||
Cough of any duration | 0.002 | |||
Missing | 0 | 1 | 1 | |
No | 278 (72.2%) | 594 (80.6%) | 872 (77.7%) | |
Yes | 107 (27.8%) | 143 (19.4%) | 250 (22.3%) | |
Reported weight loss | 0.674 | |||
No | 324 (84.2%) | 613 (83.2%) | 937 (83.5%) | |
Yes | 61 (15.8%) | 124 (16.8%) | 185 (16.5%) | |
Reported fever | 0.385 | |||
No | 320 (83.1%) | 597 (81.0%) | 917 (81.7%) | |
Yes | 65 (16.9%) | 140 (19.0%) | 205 (18.3%) | |
Reported night sweats | 0.001 | |||
No | 278 (72.2%) | 594 (80.6%) | 872 (77.7%) | |
Yes | 107 (27.8%) | 143 (19.4%) | 250 (22.3%) | |
Self-reported HIV status | 0.005 | |||
Missing | 183 | 389 | 572 | |
HIV-negative | 180 (89.1%) | 328 (94.3%) | 508 (92.4%) | |
HIV-positive | 22 (10.9%) | 20 (5.7%) | 42 (7.6%) | |
Taking TB treatment | 0.069 | |||
Missing | 182 | 340 | 522 | |
No | 199 (98.0%) | 395 (99.5%) | 594 (99.0%) | |
Yes | 4 (2.0%) | 2 (0.5%) | 6 (1.0%) | |
Previously treated for TB | <0.001 | |||
Missing | 182 | 403 | 522 | |
No | 175 (86.2%) | 391 (98.5%) | 566 (94.3%) | |
Yes | 28 (13.8%) | 6 (1.5%) | 34 (5.7%) | |
Sputum Xpert/culture result | 0.001 | |||
Missing | 66 | 600 | 666 | |
Negative | 293 (91.8%) | 185 (99.3%) | 429 (94.1%) | |
Positive | 26 (8.2%) | 1 (0.7%) | 27 (5.9%) |
CXR, chest X-ray.